- United States
- /
- Healthcare Services
- /
- NYSE:CAH
Cardinal Health Full Year 2024 Earnings: EPS Misses Expectations
Cardinal Health (NYSE:CAH) Full Year 2024 Results
Key Financial Results
- Revenue: US$226.8b (up 11% from FY 2023).
- Net income: US$852.0m (up 226% from FY 2023).
- Profit margin: 0.4% (up from 0.1% in FY 2023).
- EPS: US$3.48 (up from US$1.00 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Cardinal Health EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 10%.
The primary driver behind last 12 months revenue was the Pharmaceutical and Specialty Solutions segment contributing a total revenue of US$210.0b (93% of total revenue). Notably, cost of sales worth US$219.4b amounted to 97% of total revenue thereby underscoring the impact on earnings. The largest operating expense was General & Administrative costs, amounting to US$5.00b (76% of total expenses). Explore how CAH's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 6.8% growth forecast for the Healthcare industry in the US.
Performance of the American Healthcare industry.
The company's shares are up 9.1% from a week ago.
Risk Analysis
It's still necessary to consider the ever-present spectre of investment risk. We've identified 3 warning signs with Cardinal Health, and understanding them should be part of your investment process.
New: AI Stock Screener & Alerts
Our new AI Stock Screener scans the market every day to uncover opportunities.
• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies
Or build your own from over 50 metrics.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:CAH
Cardinal Health
Operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.
Established dividend payer with proven track record.